Joining Jack agree to fund Halo Therapeutics
Joining Jack have been raising money to fight DMD for over a year now, and now, thanks to our kind supporters, we are in a positon to use these funds to fight our fight in earnest.
Last month we agreed to fund a project that we believe will play a key part in finding a treatment for DMD.
The project is the development of a drug by Halo Therapeutics, a US based company that specialises in DMD and works in strong partnership with a number of muscular dystrophy charities. The drug, called HT-100, is a derivative of a natural compound found in a species of plant. It acts as an anti-fibrotic, meaning that it prevents scarring and build up in muscle tissue when cells are lost, something that often occurs in those who suffer from DMD, and worsens the effects of the condition.
"We are extremely pleased that Joining Jack has chosen to provide critical funds to Halo for clinical testing of HT-100 in boys with DMD," said Marc Blaustein, Halo Therapeutics CEO. "We are in a race against time to conquer DMD, and Joining Jack's financial support allows us to continue development of this promising therapeutic candidate as rapidly as possible."
For further information on Halo Therapeutics, please take a look at their website: http://www.halotherapeutics.com/
For more details on the background of HT-100, and Dart Therapeutics (of which Halo is a subsidiary) please take a look at this article: https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=3032
Joining Jack would like to thank all of our supporters who have donated and raised awareness for us since the charity formed last year - we could not have done this without all of your kindness!